USPTO trademark

ZESBLI

Under examinationUSPTOWord markClass 5

"ZESBLI" is a word mark owned by Azurity Pharmaceuticals, Inc., filed at the USPTO on October 13, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Azurity Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
ZESBLI trademark as filed
As filed with the USPTO
Status
Under examination
Since October 13, 2026
Filed
October 13, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50158630
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns ZESBLI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Azurity Pharmaceuticals, Inc.

Woburn, United States

93 trademarks in the portfolioView company

Representative

Douglas R. Wolf

Wolf Greenfield & Sacks, P.C.

Goods and services

What the mark covers

The products and services ZESBLI is filed for, grouped by Nice class.

  • pharmaceutical products and preparations for the treatment and prevention of diseases and conditions of the central and peripheral nervous system

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application office supplied data entered
  3. New application entered
FAQ

About ZESBLI

Who owns the trademark "ZESBLI"?

The USPTO trademark "ZESBLI" (application 50158630) is owned by Azurity Pharmaceuticals, Inc.

What is the status of "ZESBLI"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ZESBLI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a13a86-0471-729f-96ec-552663eb33d0
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a13a86-0471-729f-96ec-552663eb33d0",
  "object": "trademark",
  "mark_text": "ZESBLI",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50158630",
  "filing_date": "2026-10-13",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Azurity Pharmaceuticals, Inc.",
      "entity_id": "ent_019f286b-d581-7185-9ea7-9064179a9309"
    }
  ]
}